Interestingly, other members of the O-glycan biosynthesis pathway appear to be regulated by both SOX2 and GLI1, suggesting that these two TFs may promote melanoma progression through the induction of aberrant glycosylation. The gene discussed is GLI1; the disease is melanoma.